What a wonderful Plenary session we have this year!
30th November at 11.30 am, will gather experts from all over Europe to discuss the one-million dollar question which answer is obvious for some, delicate for others, but surely worth having a though on.
“Is Europe competitive enough in life sciences innovation ?”
Preceded by a 30-minute keynote presentation of Peter Gruss, who has been president of the Max Planck Society for over 12 years, and who will discuss “Academic-/biotech-/pharma-cooperations require new models”, the Plenary session will be an-hour long debate followed by a networking lunch to debrief the heated conversation that will be held from 11.30 to 1.00 am.
Check the line-up !
Keynote : “Academic-/biotech-/pharma-cooperations require new models”
Peter Gruss, former President of the Max Planck Society
Panel : “Is Europe competitive enough in life sciences innovation?”
Moderator : John Carroll, Editor EndPoints, USA
Laurent Lévy, CEO of Nanobiotix, FR
Ron Newbold, VP External R&D Innovation for Pfizer Worldwide Research and Developments, USA
Piyush Unalkat, Head of Technology Transfer Investments Innovation & Technology Investments; LUX
Frank Lescure, Managing Partner, Auriga Partners, FR
Johan Cardoen, Managing Director, VIB, Belgium (to be confirmed)
Don’t miss BioFIT Keynote & Plenary session, Amphitheater Pasteur, 30th November, 11.30 am.
